Access and pricing policy risks are intensifying and shifting across the US healthcare value chain. Understanding how they manifest across is critical for assessing the system’s vulnerabilities and how these may translate into material risks for sector companies. 

 This report provides an overview of the US healthcare market and value chain, highlighting the double materiality of the Access to Basic Services material ESG issue, and examining the convergence of US healthcare access and pricing issues alongside Sustainalytics’ Controversies Research. 

Readers of the report will learn about:

• Access to Basic Services as a material ESG issue uniquely positioned within the Healthcare sector, and how access and pricing pressures may impact margins at the industry level.
• How investors can use insights from Access to Basic Services to strengthen ESG integration, risk assessment, and long-term portfolio positioning.
• The global spillover effects of US regulatory developments, which could trigger access and affordability implications for key stakeholders.
• The US healthcare companies that demonstrate strong risk governance, pricing resilience, and access management, and how these ESG Risk Ratings attributes differentiate players that are potentially best positioned to outperform peers in managing US access and pricing pressure.